Literature DB >> 18841029

Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.

Kayhan Azadmanesh1, Minoo Mohraz, Arezoo Aghakhani, Rozita Edalat, Sara Jam, Ali Eslamifar, Mohammad Banifazl, Banafsheh Moradmand-Badie, Amitis Ramezani.   

Abstract

OBJECTIVE: Detection of hepatitis B virus (HBV) DNA without detectable hepatitis B surfaceantigen (HBsAg) is defined as occult HBV infection. In patients co-infected with human immunodeficiency virus (HIV) and HBV, HIV interferes with the natural history of HBV infection by enhancing HBV replication, leading to more severe liver disease. The aim of this study was to assess occult HBV infection in Iranian HIV-positive patients with isolated hepatitis B core antibody (anti-HBc).
METHODS: The presence of HBV-DNA was determined quantitatively in plasma samples of HIV-infected patients with isolated anti-HBc by real-time PCR using the artus HBV RG PCR kit on the Rotor-Gene 3000 real-time thermal cycler. Hepatitis C antibody (anti-HCV), alanine aminotransferase (ALT), aspartate aminotransferase (AST), HIV viral load and CD4+ count were also tested in all subjects.
RESULTS: Of 106 patients enrolled in this study, 22 subjects (20.75%, 95% CI 13-28) had isolated anti-HBc. HBV-DNA was detectable in 3 of the 22 patients (13.6%, 95% CI 0.0-28) who had isolated anti-HBc.
CONCLUSION: A serological profile of isolated anti-HBc could be associated with occult HBV infection in Iranian HIV-infected patients. Therefore the risk of transmission of HBV is probable in these patients. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841029     DOI: 10.1159/000160217

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  21 in total

Review 1.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

2.  No evidence of occult HBV infection in population born after mass vaccination.

Authors:  Mohammad Reza Aghasadeghi; Arezoo Aghakhani; Setareh Mamishi; Farahnaz Bidari-Zerehpoosh; Mohammad-Taghi Haghi Ashtiani; Shahram Sabeti; Mohammad Banifazl; Afsaneh Karami; Anahita Bavand; Amitis Ramezani
Journal:  Wien Med Wochenschr       Date:  2020-04-09

3.  Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patients.

Authors:  Arezoo Honarmand; Morteza Pourahmad; Kavous Solhjoo; Mahmoud Kohan; Mohamad Hassan Davami; Seyed Kamyar Mostafavi Zadeh
Journal:  Rep Biochem Mol Biol       Date:  2014-10

4.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.

Authors:  Stefan Reuter; Mark Oette; Frank Clemens Wilhelm; Bastian Beggel; Rolf Kaiser; Melanie Balduin; Finja Schweitzer; Jens Verheyen; Ortwin Adams; Thomas Lengauer; Gerd Fätkenheuer; Herbert Pfister; Dieter Häussinger
Journal:  Med Microbiol Immunol       Date:  2010-09-19       Impact factor: 3.402

5.  Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.

Authors:  Ma Teresa Alvarez-Muñoz; Angelica Maldonado-Rodriguez; Othon Rojas-Montes; Rocio Torres-Ibarra; Fernanda Gutierrez-Escolano; Guillermo Vazquez-Rosales; Alejandro Gomez; Onofre Muñoz; Javier Torres; Rosalia Lira
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Non-association of IL-12 +1188 and IFN-γ +874 polymorphisms with cytokines serum level in occult HBV infected patients.

Authors:  Mohammad K Arababadi; Ali A Pourfathollah; Abdollah Jafarzadeh; Gholamhossein Hassanshahi; Saeed Daneshmandi; Ali Shamsizadeh; Derek Kennedy
Journal:  Saudi J Gastroenterol       Date:  2011 Jan-Feb       Impact factor: 2.485

7.  Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients.

Authors:  Mohammad Kazemi Arababadi; Ali Akbar Pourfathollah; Abdollah Jafarzadeh; Gholamhossein Hassanshahi
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

8.  Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV.

Authors:  Amitis Ramezani; Mohammad Banifazl; Minoo Mohraz; Mehrnaz Rasoolinejad; Arezoo Aghakhani
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

9.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

10.  Occult hepatitis B infection in different high risk patients.

Authors:  Amitis Ramezani; Mohammad Banifazl; Ali Eslamifar; Masoomeh Sofian; Arezoo Aghakhani
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.